Revium Rx RVRC
OTC RVRC
$1.43 +0.00 (+0.00%)
At close: Nov 9, 2026 · 4:00 PM EST

Revium Rx (RVRC) Market Capitalization (2024 - 2026)

Updated

Revium Rx (RVRC) reported Market Capitalization of $101.42 million for Q2 2026.

Analysis

Revium Rx (RVRC) Market Capitalization (2024 - 2026) Analysis & Trends

For FY2025, Revium Rx posted Market Capitalization of $31.58 million, up 30.0% from FY2024.

  • By year, Market Capitalization came in at $24.29 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Revium Rx 86.84 Mn 75.21 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 101.42 Mn
Mar 31, 2026 101.42 Mn
Dec 31, 2025 31.58 Mn
Jun 30, 2025 30.36 Mn
Mar 31, 2025 30.36 Mn
Dec 31, 2024 24.29 Mn
API Access

Revium Rx Market Capitalization API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=market-capitalization&ticker=RVRC&period=max&api_key=YOUR_API_KEY